Fostroxacitabine bralpamide
Modify Date: 2024-01-12 11:33:09
Fostroxacitabine bralpamide structure
|
Common Name | Fostroxacitabine bralpamide | ||
|---|---|---|---|---|
| CAS Number | 2129993-56-0 | Molecular Weight | 589.37 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H30BrN4O8P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Fostroxacitabine bralpamideFostroxacitabine bralpamide (MIV-818) is an orally active Troxacitabine-based nucleotide prodrug. Fostroxacitabine bralpamide has anticancer effects[1]. |
| Name | Fostroxacitabine bralpamide |
|---|
| Description | Fostroxacitabine bralpamide (MIV-818) is an orally active Troxacitabine-based nucleotide prodrug. Fostroxacitabine bralpamide has anticancer effects[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Fostroxacitabine bralpamide (MIV-818) is highly metabolized by human hepatocytes, directing high levels of the chain-terminating nucleotide tri-phosphate to the liver. The tri-phosphate is incorporated into DNA during replication, which leads to DNA double strand breaks, DNA damage responses, and cytotoxicity[1]. |
| References |
| Molecular Formula | C22H30BrN4O8P |
|---|---|
| Molecular Weight | 589.37 |